MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression

Biomedicine and Pharmacotherapy

Volumn 71, Issue , 2015, Pages 64-69

  Ying, Xiong ^a   Li ya, Qi ^b   Feng, Zhou ^a   Yin, Wang ^a   Ji hong, Liu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

Author keywords

APC2; Cell proliferation; Human ovarian cancer; MiR 939

Indexed keywords

ADENOMATOUS POLYPOSIS COLI PROTEIN 2; APC PROTEIN; BETA CATENIN; CYCLIN D1; MESSENGER RNA; MICRORNA; MICRORNA 939; MYC PROTEIN; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; 3' UNTRANSLATED REGION; APC2 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; MIRN939 MICRORNA, HUMAN; PROTEIN BINDING;

3' UNTRANSLATED REGION; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; OVARIAN CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN RNA BINDING; TUMOR PROMOTION; UPREGULATION; WNT SIGNALING PATHWAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PROTEIN BINDING; UP-REGULATION;

EID: 84928975393     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.02.020     Document Type: Article

References (27)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics. CA: Cancer J Clin 2014, 64:9-29.
2. Ambros V. The functions of animal micrornas. Nature 2004, 431:350-355.
3. Miska E.A. How micrornas control cell division, differentiation and death. Curr Opin Genet Dev 2005, 15:563-568.
4. Zhang H., Wang Q., Zhao Q., Di W. Mir-124 inhibits the migration and invasion of ovarian cancer cells by targeting sphk1. J Ovarian Res 2013, 6:84.
5. Song L., Yang J., Duan P., Xu J., Luo X., et al. Microrna-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting lpaatbeta. Arch Biochem Biophys 2013, 535:128-135.
6. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., et al. The impact of micrornas on protein output. Nature 2008, 455:64-71.
7. Bartel D.P. Micrornas, genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Kinose Y., Sawada K., Nakamura K., Kimura T. The role of micrornas in ovarian cancer. BioMed Res Int 2014, 2014:249393.
9. Lemieux E., Cagnol S., Beaudry K., Carrier J., Rivard N. Oncogenic kras signalling promotes the wnt/beta-catenin pathway through lrp6 in colorectal cancer. Oncogene 2014.
10. Tian J., He H., Lei G. Wnt/beta-catenin pathway in bone cancers. Tumour Biol 2014, 35:9439-9445.
11. Kunttas-Tatli E., Roberts D.M., McCartney B.M. Self-association of the apc tumor suppressor is required for the assembly, stability, and activity of the wnt signaling destruction complex. Mol Biol Cell 2014, 25:3424-3436.
12. Yamulla R.J., Kane E.G., Moody A.E., Politi K.A., Lock N.E., et al. Testing models of the apc tumor suppressor/beta-catenin interaction reshapes our view of the destruction complex in wnt signaling. Genetics 2014, 197:1285-1302.
13. Formosa A., Markert E.K., Lena A.M., Italiano D., Finazzi-Agro E., et al. Micrornas, mir-154, mir-299-5p, mir-376a, mir-376c, mir-377, mir-381, mir-487b, mir-485-3p, mir-495 and mir-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene 2013.
14. Lehmann U., Streichert T., Otto B., Albat C., Hasemeier B., et al. Identification of differentially expressed micrornas in human male breast cancer. BMC Cancer 2010, 10:109.
15. Xia H., Chen S., Chen K., Huang H., Ma H. Mir-96 promotes proliferation and chemo- or radioresistance by down-regulating reck in esophageal cancer. Biomed Pharmacother 2014, 68:951-958.
16. Nymark P., Guled M., Borze I., Faisal A., Lahti L., et al. Integrative analysis of microRNA, mRNA and ACGH data reveals asbestos- and histology-related changes in lung cancer. Genes Chromosomes Cancer 2011, 50:585-597.
17. Ochoa-Hernandez A.B., Juarez-Vazquez C.I., Rosales-Reynoso M.A., Barros-Nunez P. wnt-beta-catenin signaling pathway and its relationship with cancer. Cirug Cirujanos 2012, 80:389-398.
18. Kim K.H., Seol H.J., Kim E.H., Rheey J., Jin H.J., et al. Wnt/beta-catenin signaling is a key downstream mediator of met signaling in glioblastoma stem cells. Neuro-oncol 2013, 15:161-171.
19. Hsieh I.S., Chang K.C., Tsai Y.T., Ke J.Y., Lu P.J., et al. Microrna-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the wnt/beta-catenin signaling pathway. Carcinogenesis 2013, 34:530-538.
20. Chocarro-Calvo A., Garcia-Martinez J.M., Ardila-Gonzalez S., De la Vieja A., Garcia-Jimenez C. Glucose-induced beta-catenin acetylation enhances wnt signaling in cancer. Mol Cell 2013, 49:474-486.
21. Wang D., Wise M.L., Li F., Dey M. Phytochemicals attenuating aberrant activation of beta-catenin in cancer cells. PLoS ONE 2012, 7:e50508.
22. Zhang Q.Q., Zhou D.L., Lei Y., Zheng L., Chen S.X., et al. Slit2/robo1 signaling promotes intestinal tumorigenesis through src-mediated activation of the wnt/beta-catenin pathway. Oncotarget 2014.
23. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., et al. Identification of c-myc as a target of the apc pathway. Science (New York, NY) 1998, 281:1509-1512.
24. Kolligs F.T., Bommer G., Goke B. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 2002, 66:131-144.
25. Nagayama M., Iwamoto M., Hargett A., Kamiya N., Tamamura Y., et al. Wnt/beta-catenin signaling regulates cranial base development and growth. J Dental Res 2008, 87:244-249.
26. Huang F.I., Chen Y.L., Chang C.N., Yuan R.H., Jeng Y.M. Hepatocyte growth factor activates wnt pathway by transcriptional activation of lef1 to facilitate tumor invasion. Carcinogenesis 2012, 33:1142-1148.
27. Planutiene M., Planutis K., Holcombe R.F. Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific lef1/tcf1 sub-family, is a wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion. Vascular Cell 2011, 3:28.